Literature DB >> 8526916

Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line.

M Yamada1, N Komatsu, K Okada, T Kato, H Miyazaki, Y Miura.   

Abstract

Thrombopoietin (TPO) is a cytokine which can support the proliferation and differentiation of megakaryocyte progenitor cells, and the maturation of megakaryocytes. We show here that mitogen-activated protein (MAP) kinases, Erk1 and Erk2, are involved in TPO signal transduction in the human TPO-dependent megakaryocytic cell line, UT-7/TPO. TPO induced tyrosine phosphorylation of Erk1 and Erk2 proteins in a dose and time-dependent manner. Moreover, the activation of MAP kinases was actually induced by TPO. These results suggest that MAP kinase activation is involved in the signalling pathway of TPO, as it is for other cytokines, one of which is erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526916     DOI: 10.1006/bbrc.1995.2768

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Assembling ligands in situ using bioorthogonal boronate ester synthesis.

Authors:  Sung Bin Y Shin; Ramiro D Almeida; Guillermo Gerona-Navarro; Clay Bracken; Samie R Jaffrey
Journal:  Chem Biol       Date:  2010-11-24

3.  A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.

Authors:  M Uchida; K Kirito; R Shimizu; Y Miura; K Ozawa; N Komatsu
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 4.  New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.

Authors:  Leila J Noetzli; Shauna L French; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-02       Impact factor: 8.311

Review 5.  From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Authors:  Harinder Gill; Raymond S M Wong; Yok-Lam Kwong
Journal:  Ther Adv Hematol       Date:  2017-02-01

6.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase.

Authors:  A M Whalen; S C Galasinski; P S Shapiro; T S Nahreini; N G Ahn
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.

Authors:  Asawari Korde; Lei Jin; Jian-Ge Zhang; Anuradha Ramaswamy; Buqu Hu; Saeed Kolahian; Brenda Juan Guardela; Jose Herazo-Maya; Jill M Siegfried; Laura Stabile; Margaret A Pisani; Roy S Herbst; Naftali Kaminski; Jack A Elias; Jonathan T Puchalski; Shervin S Takyar
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

8.  Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression.

Authors:  M Sugita; A Kalota; A M Gewirtz; M Carroll
Journal:  Leukemia       Date:  2012-11-06       Impact factor: 11.528

9.  Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.

Authors:  Alexandra Mazharian; Steve P Watson; Sonia Séverin
Journal:  Exp Hematol       Date:  2009-07-18       Impact factor: 3.084

10.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.